Zhiming Zhang focuses on Glial cell line-derived neurotrophic factor, Dopamine, Internal medicine, Endocrinology and Globus pallidus. His studies deal with areas such as Substantia nigra, Neuroscience, Putamen and Pharmacology as well as Glial cell line-derived neurotrophic factor. As part of one scientific family, Zhiming Zhang deals mainly with the area of Substantia nigra, narrowing it down to issues related to the Caudate nucleus, and often Neurochemical.
His Dopamine research focuses on MPTP in particular. His MPTP study integrates concerns from other disciplines, such as GDNF family of ligands, Neurturin, Cerebral dopamine neurotrophic factor and Parkinsonism. His Globus pallidus research is multidisciplinary, incorporating elements of Levodopa, Dopaminergic and Striatum.
Neuroscience, Dopamine, Substantia nigra, Endocrinology and Internal medicine are his primary areas of study. His Neuroscience research focuses on subjects like Senescence, which are linked to Physiology. His Dopamine study incorporates themes from Glial cell line-derived neurotrophic factor, Neurturin, Parkinson's disease and Midbrain.
His Glial cell line-derived neurotrophic factor research includes themes of Ventral tegmental area, Pharmacology, Parkinsonism and Neuron. Zhiming Zhang has included themes like Basal ganglia, Globus pallidus and Putamen in his Substantia nigra study. His Huntingtin study in the realm of Internal medicine interacts with subjects such as Messenger RNA and Triglyceride.
Zhiming Zhang spends much of his time researching Parkinson's disease, Putamen, Neuroscience, Endocrinology and Internal medicine. His research in Parkinson's disease intersects with topics in Striatum and Dopamine. Zhiming Zhang specializes in Dopamine, namely MPTP.
His Putamen study combines topics from a wide range of disciplines, such as Basal ganglia, Convection-Enhanced Delivery and Surgery. His research integrates issues of Substantia nigra and Caudate nucleus in his study of Basal ganglia. His work on Diabetes mellitus, Metabolic disorder and Clinical chemistry as part of general Endocrinology research is often related to Triglyceride, thus linking different fields of science.
Zhiming Zhang mainly focuses on Distribution, Parkinson's disease, Internal medicine, Putamen and Endocrinology. The study incorporates disciplines such as Glial cell line-derived neurotrophic factor, Neurturin, Neuroprotection and Dopamine in addition to Distribution. Zhiming Zhang has researched Parkinson's disease in several fields, including Basal ganglia and Neuroscience, Neuron.
He integrates Internal medicine with Messenger RNA in his research. His Substantia nigra research extends to the thematically linked field of Putamen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Functional recovery in parkinsonian monkeys treated with GDNF.
D M Gash;Z Zhang;A Ovadia;W A Cass.
Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease
Navin Maswood;Jennifer Young;Edward Tilmont;Zhiming Zhang.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys
Richard Grondin;Zhiming Zhang;Ai Yi;Wayne A. Cass.
Critical decline in fine motor hand movements in human aging
C.D. Smith;G.H. Umberger;E.L. Manning;J.T. Slevin.
Point source concentration of GDNF may explain failure of phase II clinical trial.
Michael Francis Salvatore;Yi Ai;Brent Fischer;Amanda M. Zhang.
Experimental Neurology (2006)
Neuroprotective and neurorestorative properties of GDNF.
Don M. Gash;Zhiming Zhang;Greg Gerhardt.
Annals of Neurology (1998)
Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease
J. T. Greenamyre;R. V. Eller;Zhiming Zhang;A. Ovadia.
Annals of Neurology (1994)
Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum
Richard Grondin;Michael D. Kaytor;Yi Ai;Peter T. Nelson.
Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys
Aliza Ovadia;Zhiming Zhang;Don M. Gash.
Neurobiology of Aging (1995)
Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects.
Yi Ai;William Markesbery;Zhiming Zhang;Richard Grondin.
The Journal of Comparative Neurology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: